Schedule 13G ownership disclosure
KEMPHARM, INC
Security class unavailable · CUSIP: 488445107
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-011511
- Form type
- SC 13G
- Filer
- Delaware Street Capital Master Fund, L.P.
- CIK
- CIK 1648576
- Filed
- Jan 17, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership